Danimer Scientific (DNMR)
(Real Time Quote from BATS)
$0.44 USD
0.00 (-0.83%)
Updated Oct 2, 2024 11:04 AM ET
2-Buy of 5 2
F Value D Growth C Momentum F VGM
Balance Sheet
Fiscal Year End for Danimer Scientific, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 59 | 63 | 286 | 378 | 6 |
Receivables | 16 | 20 | 21 | 7 | 5 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 25 | 33 | 25 | 14 | 7 |
Other Current Assets | 8 | 10 | 8 | 5 | 1 |
Total Current Assets | 108 | 125 | 340 | 402 | 19 |
Net Property & Equipment | 445 | 454 | 316 | 107 | 72 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 31 | 31 | 13 | 13 | 28 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 78 | 81 | 147 | 2 | 2 |
Deposits & Other Assets | 17 | 2 | 2 | 2 | 3 |
Total Assets | 698 | 712 | 839 | 546 | 145 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 5 | 15 | 21 | 11 | 8 |
Current Portion Long-Term Debt | 1 | 2 | 0 | 25 | 9 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 5 | 5 | 19 | 9 | 10 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 1 | 0 | 0 | 2 | 5 |
Total Current Liabilities | 16 | 25 | 43 | 50 | 34 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 1 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 381 | 286 | 261 | 31 | 74 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 1 | 1 | 10 | 1 | 3 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 420 | 335 | 338 | 107 | 128 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 732 | 676 | 619 | 501 | 67 |
Retained Earnings | -454 | -299 | -119 | -63 | -50 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 278 | 378 | 500 | 439 | 17 |
Total Liabilities & Shareholder's Equity | 698 | 712 | 839 | 546 | 145 |
Total Common Equity | 278 | 378 | 500 | 439 | 17 |
Shares Outstanding | 102.80 | 101.80 | 100.60 | 84.50 | NA |
Book Value Per Share | 2.70 | 3.71 | 4.97 | 5.19 | 0.00 |
Fiscal Year End for Danimer Scientific, Inc falls in the month of December.
All items in Millions except Per Share data.
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 40 | 57 | 59 | 77 | 91 |
Receivables | 12 | 13 | 16 | 13 | 14 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 26 | 26 | 25 | 27 | 30 |
Other Current Assets | 9 | 9 | 8 | 10 | 10 |
Total Current Assets | 87 | 105 | 108 | 127 | 145 |
Net Property & Equipment | 434 | 440 | 445 | 450 | 454 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 31 | 31 | 31 | 31 | 31 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 76 | 77 | 78 | 79 | 79 |
Deposits & Other Assets | 18 | 17 | 17 | 15 | 15 |
Total Assets | 667 | 689 | 698 | 721 | 744 |
Liabilities & Shareholders Equity | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 3 | 4 | 5 | 4 | 4 |
Current Portion Long-Term Debt | 7 | 1 | 1 | 1 | 2 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 5 | 6 | 5 | 6 | 5 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 1 | 1 | 1 | 0 | 1 |
Total Current Liabilities | 19 | 16 | 16 | 15 | 15 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 387 | 384 | 381 | 379 | 376 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 5 | 1 | 1 | 1 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 433 | 433 | 420 | 417 | 414 |
Shareholders Equity | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 738 | 737 | 732 | 719 | 705 |
Retained Earnings | -504 | -481 | -454 | -415 | -375 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 234 | 256 | 278 | 304 | 330 |
Total Liabilities & Shareholder's Equity | 667 | 689 | 698 | 721 | 744 |
Total Common Equity | 234 | 256 | 278 | 304 | 330 |
Shares Outstanding | 116.60 | 114.20 | 102.80 | 102.00 | 101.90 |
Book Value Per Share | 2.01 | 2.24 | 2.70 | 2.98 | 3.24 |